Australia's University of Queensland (UQ) researchers are calling for an urgent review of low influenza vaccination rate...
Japanese pharmaceutical firm Takeda has announced that its dengue vaccine candidate, TAK-003, prevented 8...
A new study jointly conducted by South Korea-based International Vaccine Institute (IVI) and collaborators shows multido...
SINOVAC Biotech, a leading provider of biopharmaceutical products in China, has received the World Health Organization (...
Daiichi Sankyo has announced the current progress of development of DS-5670, an mRNA vaccine, being evaluated in Japan a...
Moderna and Takeda have announced to transfer the marketing authorization in Japan for Moderna’s COVID-1...
South Korea-based International Vaccine Institute (IVI) and Armauer Hansen Research Institute (AHRI), established by the...
The University of Auckland in New Zealand has received budget funding of $40.7 million for development of novel mRNA vac...
The World Health Organization (WHO) has issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by ...
The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea (ROK),...
South Korea-based SK Bioscience has secured another approval for in-house vaccine. SK Bioscience obtained an export lic...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is providing funding of up to $19.3 million to suppo...
Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...
Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...
On 20 April 2022, Sanofi launched Evolutive Vaccine Facility (EVF) in Singapore. A first-of-its-kind, the...
Takeda Pharma has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (M...
The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed ...
US-based Novavax, Inc. and Serum Institute of India have announced that the Thailand Food and Drug Administration (Thai ...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...
A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable a...
Singapore-based Prestige Biopharma and Vaxine have entered into a memorandum of understanding (MoU) to collabo...
Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1...
The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore has been closely reviewing the data regarding the need...
The Australian government is investing more than $100 million for seasonal influenza vaccines to protect Aus...
The state of Victoria (Australia) and Korea have signed a Memorandum of Understanding (MoU) to collaborate on mRNA vacci...
Around 400 of Asia’s renowned Biopharmaceutical manufacturing and logistics leadership personnel will gather in-pe...
Denmark's Bavarian Nordic has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-base...
A group of scientists at the University of Auckland in New Zealand are working towards developing an mRNA-based vaccine ...
What are the unique highlights of the COVID-19 vaccine- VLA2001 under trial? While different companies have taken vario...
Sinovac Biotech, based in China, has signed a letter of agreement with the Ecuadorian Ministry of Public Healt...
The World Health Organization (WHO), the Republic of Korea and the WHO Academy have announced the establishment of a glo...
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and the Murdoch Children’s Research Institute...
CanSino Biologics Inc. has announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)...
The Health Sciences Authority (HSA) has granted an interim authorisation under the Pandemic Special Access Route (PSAR) ...
The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare (MOHW), Republic of ...
The Therapeutic Goods Administration (TGA) in Australia has provisionally approved the Moderna COVID-19 vaccine, SPIKEVA...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, has announced that it will expand its collaborat...
Researchers at AIDS Institute, Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMe...
Intradermal COVID-19 vaccination studies are emerging in a global effort to multiply available doses by harnessing skin ...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced that the Russian one-shot ...
What are your views on the ongoing threat being imposed by the COVID-19 variants across the globe? How can those be best...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has launched a new 'Call for Proposals' to...
US-based Novavax, Inc. has announced that New Zealand's Medsafe has granted provisional approval of NVX-CoV237...
EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...
The coronavirus crisis which has enraged the world has also opened up debates around IP and public health. The gen...
US-based Anixa Biosciences, Inc. has announced that the Japanese Patent Office has issued a Decision to Grant ...
CEPI, the Coalition for Epidemic Preparedness Innovations, has announced the latest award under its $200 million pr...
Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...
The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people a...
The International Vaccine Institute (IVI) in South Korea and the National Vaccine Institute (NVI) of Thailand have signe...
Novavax, Inc. has announced that Australia's Therapeutic Goods Administration (TGA) has granted approval for p...
The COVID-19 pandemic may well be the worst public health crisis in modern history. But today, the global health system ...
US-based Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have annou...
Novavax, Inc. and Serum Institute of India have announced a regulatory submission to the South African Health Products R...
GlaxoSmithKline (GSK) Singapore has launched a new vaccine to help protect against shingles, Shingrix, in...
Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency U...
Indian firm Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and South Korean firm SK bioscience (SK) have an...
US-based Brand Institute has announced its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SP...
American firm Moderna has announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing aut...
HDT Bio Corp., a US-based developer of immunotherapies for oncology and infectious diseases, and Korean biotech Quratis ...
US-based Moderna, Inc. has announced an agreement in principle with the Australian Government to build a state-of-the-ar...
A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...
After months of collaborative development, Ireland-based Aerogen and China’s CanSinoBIO have announced a developme...
Japan-based Shionogi & Co. has recently announced the results from the Japanese Phase 1/2 clinical trial of S-268019...
The International Vaccine Institute (IVI) is joining hands with SK bioscience, a leading biopharmaceutical company in So...
Victorian scientists and manufacturers have created Australia’s first mRNA COVID-19 vaccine candidate – Aust...
The Coalition for Epidemic Preparedness Innovations (CEPI) and Taiwan-based Medigen Vaccine Biologics Corp. (MVC) will c...
GenScript Biotech Corporation, a leading global biotechnology company, and BioComo Incorporation, a drug discovery ventu...
Prestige BioPharma (PBP), a Singapore-based biopharmaceutical with operations in USA and South Korea, has announced the ...
GenScript ProBio, Suzhou Abogen Biosciences Technology Co. and Walvax Biotechnology Co. have announced a collaboration o...
Enzychem Lifesciences and Cadila Healthcare, a part of the Zydus Group in India, have entered a Manufacturing Licen...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Aga Khan University (AKU) have announced a n...
New Zealand (NZ) based University of Auckland’s medical faculty will lead a multi-million dollar government-funded...
The researchers from the Sydney Institute for Infectious Diseases at the University of Sydney, UNSW Sydney&rsq...
China-based Clover Biopharmaceuticals and Norway-based CEPI, the Coalition for Epidemic Preparedness Innovat...
China-based SINOVAC Biotech has announced that results from blind data analysis of a multi-centre, case-driven, ran...
mRNA Victoria, the agency of the Australian State of Victoria Government charged with building the State's mRNA man...
The government has approved a fund of 3,625 million baht for two Thai vaccine projects against COVID-19, ChulaCov19 mRNA...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Q2 Solutions, a wholly owned subsidiary of ...
US-based Novavax, Inc. and Serum Institute of India have announced that the National Agency of Drug and Food Contro...
There is a common pearl of Indian wisdom that encourages parents to let their children play outside in the sun, rain, ga...
Taiwan's Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an indep...
Daiichi Sankyo has announced the progress of development of DS-5670, an mRNA vaccine in Japan, being evaluated against t...
There’s been a significant breakthrough in the development of a vaccine to prevent hookworm infection, a parasite ...
The Health Sciences Authority (HSA) in Singapore has granted an interim authorisation under the Pandemic Special Access ...
1. Who Is Eligible for a COVID Booster Shot? As of now, the U.S. Centers for Disease Control and Prevention (CD...
Taiwan-based Medigen Vaccine Biologics Corporation has recently stated that MVC-COV1901, a recombinant protein vacc...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Gamaleya National Research Cent...
Norway-based Coalition for Epidemic Preparedness Innovations, or CEPI, has launched a new call for proposals to fund cli...
American firm Moderna, Inc. will build a state-of-the-art mRNA facility in Africa with the goal of producing u...
The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine (Mosquirix)...
To boost Singapore’s biopharmaceutical sector, Australia-based Lendlease is commencing construction of a large-sca...
The International Vaccine Institute (IVI) in South Korea, the Texas Children’s Hospital Center for Vaccine Develop...
Jiangsu Recbio Technology and Shenzhen Rhegen Biotechnology have recently signed a joint venture agreement to establish ...
Indian vaccine manufacturer Serum Institute of India (SII) and its US-based partner Novavax, have announced a regulatory...
